STRAPHARM is a French CDMO specializing in the design, development, and manufacturing of natural health products, with a focus on food supplements and cosmetics in dry forms. With over 30 years of experience, the company offers a wide range of products including tablets, capsules, chewing gum, powders, sachets, jars, and doypacks. Their mission is centered around simplicity, performance, and promoting well-being for People, Animals, and the Environment.
The company prioritizes innovation, quality, trust, and customer satisfaction as its core values, which have been instrumental in its growth and success. Certified with ISO 22000 and ECOCERT, STRAPHARM adheres to high standards in its manufacturing processes.
Founded in 1988, STRAPHARM operates within the Food and Beverage, Health Care, Manufacturing, and Nutrition industries, solidifying its position as a prominent player in the natural health product market.
With a commitment to natural health product development, STRAPHARM presents an intriguing opportunity for venture capital investment in the evolving health and wellness sector. Focused on sustainability and customer well-being, the company showcases a strong foundation and potential for further growth and market expansion.
There is no investment information
No recent news or press coverage available for STRAPHARM.